DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18381
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGaikwad, Anil Bhanudas-
dc.date.accessioned2025-03-17T04:33:19Z-
dc.date.available2025-03-17T04:33:19Z-
dc.date.issued2024-08-
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/fcp.13031-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18381-
dc.description.abstractBeing amongst the leading factors of death and distress, chronic kidney disease (CKD) has affected around 850 million people globally. The Wnt/β-catenin axis is vital for maintaining kidney homeostasis, from nephron generation to overall management. The β-catenin growth factor is typically not expressed in the adult kidney; however, its expression is found to increase under stress and injury conditions. It is categorised as canonical and non-canonical based on β-catenin availability, which mounts promising targets for ameliorating CKD. Hence, modulation of the Wnt/β-catenin signalling for CKD management is of utmost relevance.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectPharmacyen_US
dc.subjectChronic kidney disease (CKD)en_US
dc.subjectKidney homeostasisen_US
dc.titleWnt/beta-catenin modulation: A promising frontier in chronic kidney disease managementen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.